Bio-Techne Corporation entered into a merger agreement with Merck KGaA, Darmstadt, Germany, to be acquired for $73.00 per share in cash. The transaction is subject to shareholder approval and customary closing conditions. Bio-Techne Corporation is a life sciences company that provides tools and reagents for research and clinical diagnostics.

Bio-Techne Corporation and Merck KGaA, Darmstadt, Germany, have executed an Agreement and Plan of Merger, announcing a proposed acquisition of Bio-Techne by Merck KGaA. The transaction is subject to shareholder approval and several conditions. Bio-Techne is a life sciences tools and reagents company providing biological and biological-related products for research and clinical diagnostics.